GALECTO Trademark

Trademark Overview


On Thursday, September 17, 2020, a trademark application was filed for GALECTO with the United States Patent and Trademark Office. The USPTO has given the GALECTO trademark a serial number of 90188961. The federal status of this trademark filing is REGISTERED as of Tuesday, September 28, 2021. This trademark is owned by Galecto Biotech AB. The GALECTO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical, medical and veterinary medicinal products for treatment of cancer, fibrotic diseases, autoimmune disease, neurodegenerative diseases, viral infections, acute inflammatory conditions, transplant rejection

Providing medical research information, namely, biological, chemical, pharmaceutical and clinical data in the field of diagnostic, prophylactic and therapeutic properties of pharmaceuticals for treatment of cancer, fibrotic diseases, autoimmune diseases, neurodegenerative diseases, viral infections, acute inflammatory conditions, transplant rejection, and indications hereof
galecto

General Information


Serial Number90188961
Word MarkGALECTO
Filing DateThursday, September 17, 2020
Status700 - REGISTERED
Status DateTuesday, September 28, 2021
Registration Number6497206
Registration DateTuesday, September 28, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 13, 2021

Trademark Statements


Goods and ServicesPharmaceutical, medical and veterinary medicinal products for treatment of cancer, fibrotic diseases, autoimmune disease, neurodegenerative diseases, viral infections, acute inflammatory conditions, transplant rejection
Goods and ServicesProviding medical research information, namely, biological, chemical, pharmaceutical and clinical data in the field of diagnostic, prophylactic and therapeutic properties of pharmaceuticals for treatment of cancer, fibrotic diseases, autoimmune diseases, neurodegenerative diseases, viral infections, acute inflammatory conditions, transplant rejection, and indications hereof

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 27, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 27, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGalecto Biotech AB
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressCopenhagen 2200
SE

Party NameGalecto Biotech AB
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressCopenhagen 2200
SE

Party NameGalecto Biotech AB
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressCopenhagen 2200
SE

Trademark Events


Event DateEvent Description
Tuesday, September 28, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, July 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 23, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 9, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 7, 2021ASSIGNED TO LIE
Wednesday, March 10, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, February 9, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 9, 2021LETTER OF SUSPENSION E-MAILED
Tuesday, February 9, 2021SUSPENSION LETTER WRITTEN
Tuesday, February 9, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, February 9, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 9, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, February 9, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, February 1, 2021ASSIGNED TO EXAMINER
Tuesday, October 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 24, 2020TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, September 24, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, September 21, 2020NEW APPLICATION ENTERED IN TRAM